Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: David Pohl, IMO was NOT FOR a R/S.
The Board of Directors is aware that a reverse stock split may be a strategy to be considered to achieve an increase in the share price. However, such action would not be prudent in the absence of adequate assurance that ongoing business developments would be sufficiently positive to keep the shares trading near or above the new market price achieved by the reverse stock split. Such action is not being considered at the present time.

http://www.ptsc.com/news/press_releases/2007notes.asp

Be well

Share
New Message
Please login to post a reply